Skip to content
Peptide research

Cerluten

Also known as Brain Bioregulator
Category
Bioregulators
Administration routes
Oral
Regulatory status
Not FDA-approved

What it is

A bioregulator peptide complex from bovine brain tissue, marketed to support cognition and slow age-related brain decline via effects on neuron gene expression. Human evidence is minimal, cognitive and metabolic benefit claims are speculative, and the neuroprotective signal is low-confidence, mostly animal-derived. Most supply is unregulated research-grade product of uncertain purity, plus an unresolved prion concern given its origin. Not FDA-approved.

Read Full record

Studied uses & evidence

Studied uses(3)

  • Support for cognitive function in elderly patients

    Speculative

    A developer clinical report exists; independent confirmation is lacking.

  • Neuroprotective activity in age-related CNS decline

    Low

    Extensive animal data support the peptide class, but no direct testing of Cerluten itself.

  • Normalization of brain cell metabolism

    Speculative

    Mechanism-based only; cited studies used a different peptide in cell cultures, not Cerluten in humans.

Evidence limits

Evidence Level
Very Limited Evidence

Clinical evidence for Cerluten consists primarily of small open-label studies conducted at the St. Petersburg Institute of Bioregulation and Gerontology. These studies report improvements in cognitive function, memory, and neurological symptoms in elderly patients, but lack randomization, blinding, and placebo controls. No independent Western clinical trials have been conducted. The neuroprotective peptide review (PMID 24738258) provides context on the broader class but does not constitute direct evidence for Cerluten specifically.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

General cautions

  • Pregnancy or breastfeeding

    Absolute

    No human reproductive safety data exists for this peptide. Effects on fetal development are unknown.

  • Children under 18

    Absolute

    No pediatric safety data. Not recommended for use in minors.

  • Known hypersensitivity

    Absolute

    Discontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).

Risk summary(3)

Risks = level of concern: High · Moderate · Low · Theoretical

  • Allergic reaction to animal-derived peptides

    Low
  • Prion disease concerns (bovine brain origin)

    Theoretical
  • Lack of independent quality control

    High
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.